Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 553.4 g/mol |
---|---|
Molecular Formula | C23H30Cl2N8O4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 552.1767069 g/mol |
Monoisotopic Mass | 552.1767069 g/mol |
Topological Polar Surface Area | 140 A^2 |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 796 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
22
PharmaCompass offers a list of Copanlisib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Copanlisib manufacturer or Copanlisib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Copanlisib manufacturer or Copanlisib supplier.
PharmaCompass also assists you with knowing the Copanlisib API Price utilized in the formulation of products. Copanlisib API Price is not always fixed or binding as the Copanlisib Price is obtained through a variety of data sources. The Copanlisib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Copanlisib hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Copanlisib hydrochloride, including repackagers and relabelers. The FDA regulates Copanlisib hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Copanlisib hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Copanlisib hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Copanlisib hydrochloride supplier is an individual or a company that provides Copanlisib hydrochloride active pharmaceutical ingredient (API) or Copanlisib hydrochloride finished formulations upon request. The Copanlisib hydrochloride suppliers may include Copanlisib hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Copanlisib hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Copanlisib hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Copanlisib hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Copanlisib hydrochloride GMP manufacturer or Copanlisib hydrochloride GMP API supplier for your needs.
A Copanlisib hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Copanlisib hydrochloride's compliance with Copanlisib hydrochloride specifications and serves as a tool for batch-level quality control.
Copanlisib hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Copanlisib hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Copanlisib hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Copanlisib hydrochloride EP), Copanlisib hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Copanlisib hydrochloride USP).